Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shariful Hasan Sumon"'
Autor:
Md. Shariful Hasan Sumon, Carolyn A Young, Wan Aliaa Wan Sulaiman, Hamidon Basri, Hasnur Zaman Hashim, Fan Kee Hoo, Johnson Stanslas
Publikováno v:
The Cochrane Library
Cochrane Database Syst Rev
Cochrane Database Syst Rev
Authors have made no progress with completing the review since the protocol was published, in 2015.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8ce06f61efcbfb4f5b9ed61cd0b13d
https://doi.org/10.1002/14651858.cd012000
https://doi.org/10.1002/14651858.cd012000
Autor:
Charng Choon Wong, Roger M. Phillips, Johnson Stanslas, Shiran Mohd Sidik, Nagarajan Periasamy, Sreenivasa Rao Sagineedu, Shariful Hasan Sumon, Nordin H. Lajis
Publikováno v:
The FASEB Journal. 28
The inability of anticancer drugs to penetrate through the tumor within their respective pharmacokinetic lifespan to destroy all the tumor cells is recognized as one of the factors that lead to poo...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce2b563188c67e3159a98164e65945f2
https://doi.org/10.1096/fasebj.28.1_supplement.1048.4
https://doi.org/10.1096/fasebj.28.1_supplement.1048.4
Autor:
Charng Choon Wong, Nordin H. Lajis, Roger M. Phillips, Shiran Mohamad Sidik, Johnson Stanslas, Shariful Hasan Sumon, Sreenivasa Rao Sagineedu
Publikováno v:
Environmental toxicology and pharmacology. 38(2)
Andrographolide (AGP) is the main bioactive constituent isolated from the traditional medicinal, Andrographis paniculata which contributes towards its various biological activities, including anticancer property. In this study, a series of new AGP de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6278e692576980b03213e27c6c0b1016
https://pubmed.ncbi.nlm.nih.gov/25168151
https://pubmed.ncbi.nlm.nih.gov/25168151
Autor:
Roger M. Phillips, Shariful Hasan Sumon, Johnson Stanslas, Paul M. Loadman, Charng Choon Wong, Shiran Mohd Sidik, Nordin Haji Lajis, Sreenivasa Rao Sagineedu, Nararajan Periasamy
Publikováno v:
Investigational new drugs. 32(5)
Limited tumor penetrability of anti-cancer drugs is recognized as one of the major factors that lead to poor anti-tumor activity. SRJ09 (3,19-(2-bromobenzylidene) andrographolide) has been identified as a lead anti-cancer agent for colon cancer. Rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99f025c4e6d2e0d6c437c6ed30178f1d
https://pubmed.ncbi.nlm.nih.gov/24875131
https://pubmed.ncbi.nlm.nih.gov/24875131
Autor:
Shariful Hasan Sumon, Shiran Mohd Sidik, Sreenivasa Rao Sagineedu, Johnson Stanslas, Roger M. Phillips, Nordin Haji Lajis, Charng Choon Wong
Publikováno v:
Cancer Research. 74:4454-4454
SRJ09 (3,19-(2-bromobenzylidene)andrographolide) was shown to be more selective towards breast and colon cancers in USA NCI 60 cancer cell line screen, thus conferring it as lead anticancer agent (Jada et al (2008) Br J Pharmacol, 155(5):641-54). The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d0240b2af89d584a6bf67bf12a72b74
https://doi.org/10.1158/1538-7445.am2014-4454
https://doi.org/10.1158/1538-7445.am2014-4454
Autor:
Roger M. Phillips, Charng Choon Wong, Sreenivasa Rao Sagineedu, Nordin Haji Lajis, Johnson Stanslas, Shiran Mohd Sidik, Shariful Hasan Sumon
Publikováno v:
Molecular Cancer Therapeutics. 12:C147-C147
SRJ09 (3,19-(2-bromobenzylidene)andrographolide) has been identified as a lead anticancer agent on the basis of its selectivity towards breast and colon cancers in the USA NCI 60 cancer cell lines screen (Jada et al (2008) Br J Pharmacol, 155(5):641-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f011cd15fdbc13839b149000e129a74
https://doi.org/10.1158/1535-7163.targ-13-c147
https://doi.org/10.1158/1535-7163.targ-13-c147